Noticias y vídeos - NANOVIBRONIX INC.

Elmsford, NY, Dec. 21, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc. (the “Company”) (NASDAQ: NAOV) announced today that the Company’s Special Meeting of Stockholders, scheduled for 10:00 a.m. Eastern time today, December 21, 2021, has been adjourned to allow for more time for stockholders to vote due to a lack of quorum. The meeting has been scheduled to reconvene on December 29, 2021 at 10:00 a.m. Eastern time and will be held virtually online at...

Elmsford, NY, Dec. 08, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it will showcase its PainShield products at the Workers’ Compensation Institute’s (WCI) 75th Annual Workers’ Compensation Educational Conference on December 12-15, 2021 at the Orlando World Center Marriott in Orlando, Florida. Brian Murphy, CEO of...

Elmsford, NY, Dec. 07, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced positive interim results from an independent, real world patient study of its UroShield at Southampton University Health Sciences. Brian Murphy, CEO of Nanovibronix, stated, “Interim results and observations from both the patient qualitative work and...

Elmsford, NY, Dec. 02, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that sales of its Painshield device to the Veterans Administration (VA) has been accelerating. Brian Murphy, CEO of Nanovibronix, stated, “Sales of our PainShield device to the VA commenced mid-summer, and we are pleased to report that adoption is...

Elmsford, NY, Oct. 28, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided the following business update and letter to shareholders from its Chief Executive Officer, Brian Murphy: "It is my sincere pleasure to address you through this letter and inform you of the progress, opportunities and potential of NanoVibronix. I hope to use this letter as a...

Elmsford, NY, Oct. 11, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced positive results from a randomized, double-blind study conducted at Birmingham Orthopedic and Sports Specialists in Birmingham, Alabama. Clinicians at Birmingham Orthopedic and Sports Specialists recently conducted a randomized, double-blind study to...

Elmsford, NY, Sept. 29, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has entered the worker’s compensation market with the signing of a Provider Participation Agreement with Orchid Medical, a national provider of integrated ancillary and surgical cost containment solutions specifically for the workers’ compensation...

Elmsford, NY, Sept. 14, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it is launching a new, transdermal gel containing Nano-Cannabidiol (CBD) for the treatment of joint pain and reducing inflammation. Brian Murphy, CEO of NanoVibronix, stated, “Adding CBD gel to our portfolio of products should materially expand our...

Elmsford, NY, Aug. 16, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV) , a Healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it intends to enter the Over-the-Counter (OTC) pain relief market with the introduction of PainShield RELIEF™, a non-prescription ultrasound therapy device that delivers fast pain relief for nerve and soft tissue damage. Brian Murphy, Chief...

ELMSFORD, NY, Aug. 11, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV) , a Healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the Therapeutic Goods Administration (TGA), The Australian Regulatory body for Therapeutic Devices, has granted approval for the Company’s PainShield for use by patients in Australia. This approval follows TGA’s recent approval of the...

Elmsford, NY, July 22, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (“SAW”) Portable Ultrasonic Therapeutic Devices, today announced that The Journal of Medical & Surgical Urology is publishing an article with overwhelmingly positive findings from a study of patients that used its UroShield in real world settings. “This independent study is further proof of the effectiveness and...

ELMSFORD, N.Y., June 03, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (“SAW”) Portable Ultrasonic Therapeutic Devices, today provided an update on its business. Received CMS Approval for Reimbursement Launched PainShield Plus® Expanded Distribution with UPPI Refining Manufacturing Processes and Expanding Capacity Sufficiently Capitalized “We are nearing an inflection point in our...

Elmsford, NY, April 27, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc . (the “ Company ”) (NASDAQ: NAOV ) announced today that the Company’s Special Meeting of Stockholders, which had been previously adjourned to 10:00 a.m. Eastern time today, April 27, 2021, has been once again adjourned to allow for more time for stockholders to vote. The meeting has been scheduled to reconvene on May 6, 2021 at 10:00 a.m. Eastern time and will be held virtually online at...

ELMSFORD, N.Y., April 26, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has expanded its reimbursement approval of the company’s PainShield™ product by adding the device to its Durable Medical Equipment (DME) schedule. Effective immediately,...

Elmsford, NY, April 14, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc . (the “ Company ”) (NASDAQ: NAOV ) announced today that the Company’s Special Meeting of Stockholders, which had been previously adjourned to 10:00 a.m. Eastern time today, April 14, 2021, has been once again adjourned to allow for more time for stockholders to vote. The meeting has been scheduled to reconvene on April 27, 2021 at 10:00 a.m. Eastern time and will be held virtually online at...

ELMSFORD, N.Y., April 01, 2020 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV) , a medical device company that produces the PainShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic therapeutic device, today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved its PainShield™ for reimbursement for Medicare beneficiaries on a national basis effective January 2020. “PainShield provides an effective alternative to pharmaceuticals for pain management...

ELMSFORD, N.Y., March 27, 2020 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV) , a medical device company that produces the UroShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic therapeutic device which attaches to an indwelling catheter and has been clinically proven to mitigate Catheter Associated Urinary Tract Infection (CAUTI), as well as reducing pain and blockages, today announced that it has reached out to regulatory agencies around the world to inform them of the potential...

ELMSFORD, NY / ACCESSWIRE / August 13, 2019 / NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company’s proprietary and patented low intensity, SAW (Surface Acoustic Wave) ultrasound technology, today announced that it has signed a distribution agreement with ProTrade Systems, a medical equipment distributor in the U.S. for thousands of patients, elite athletes, athletic trainers, professional...

ELMSFORD, NY / ACCESSWIRE / July 23, 2019 / NanoVibronix, Inc ., (NASDAQ: NAOV) , a medical device company that produces the PainShield ® surface acoustic wave (SAW) device, which utilizes the Company’s proprietary and patented low intensity, SAW ultrasound technology, today announced that it has entered into an non-exclusive license agreement with Ideal Medical International Limited pursuant to which Ideal Medical International Limited will serve as a non-exclusive international distributor...

ELMSFORD, N.Y., June 24, 2019 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV) , a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company’s proprietary and patented low intensity, SAW ultrasound technology, today announced that it closed a private placement transaction in which it issued and sold to existing stockholders 1.6 million Series E convertible preferred stock and 1.6 million 7-year warrants to purchase Series E...